Biokraft International AB reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 114.69 million compared to SEK 98.04 million a year ago. Revenue was SEK 135.14 million compared to SEK 101.07 million a year ago. Net loss was SEK 12.07 million compared to SEK 41.31 million a year ago. Basic loss per share from continuing operations was SEK 0.28 compared to SEK 1.41 a year ago.
For the six months, sales was SEK 227.49 million compared to SEK 195.87 million a year ago. Revenue was SEK 265.23 million compared to SEK 199.42 million a year ago. Net loss was SEK 70.71 million compared to SEK 51.45 million a year ago. Basic loss per share from continuing operations was SEK 1.63 compared to SEK 1.8 a year ago.